GAO to FDA: Do more to encourage drug manufacturing innovation

The Government Accountability Office on Friday released a report calling on the FDA to better encourage the adoption of advanced drug manufacturing practices, particularly as interviews with 15 stakeholders from industry said delays in adopting advanced tech are related to regulatory uncertainties.